Factors influencing no-reflow phenomenon in patients with ST-segment myocardial infarction treated with primary percutaneous coronary intervention
Scindeks Asistent Scindeks Asistent — sistem za ozbiljne časopise i one koji to žele da postanu
PDF (engleski)

Sažetak

Background/Aim. It is not know which factors influ­ence no-reflow phenomenon after successful primary percutaneous intervention (pPCI) in patients with myo­cardial infarction with ST elevation (STEMI). The aim of this study was to estimate predictive value of some admission characteristics of patients with STEMI, who underwent pPCI, for the development of no-reflow phenomenon. Worse clinical outcome in patients with no-reflow points to importance of selection and aggres­sive treatment in a group at high risk. Methods. This was retrospective and partly prospective study which included 491 consecutive patients with STEMI, admitted to a single centre, during the period from 2000 to Sep­tember 2015, who underwent pPCI. Descriptive charac­teristics of the patients, presence of classical risk factors for cardiovascular disease, total ischemic time and clini­cal features at admission were all estimated as predictors for the development of no-reflow phenomenon. No-re­flow phenomenon is defined as the presence of throm­bolysis in myocardial infarction (TIMI) < 3 coronary flow at the end of the pPCI procedure, or ST-segment resolution by less than 50% in the first hours after the procedure. The significance of the predictive value of some parameters was evaluated by univariate and multi­variate regression analysis. In univariate analysis, we used the χ2 test and Mann Whitney and Student's t-tests. Results. No-reflow phenomenon was detected in 84 (17.1%) patients (criteria used: TIMI < 3 coronary flow) and in 144 (29.3%) patients (criteria used: ST-sement resolution < 50%). Patients older than 75 years [odds ratio (OR) = 2.53; 95% confidence interval (CI) 1.48–4.33; p = 0.001] and those who had Killip class at admis­sion higher than 1 had increased risk to achieve TIMI-3 flow after pPCI. Killip class higher than 1 (OR 1.59; 95% CI 1.23–2.04; p < 0.001), left anterior descendent artery (LAD) as infarct related artery (IRA) and total ischemic time higher than 4 hour were associated with increased risk to failure of rapid ST segment resolution after pPCI. Conclusion. Older age and Killip class were main predictors of TIMI < 3 flow, and Killip class, LAD as IRA and longer total ischemic time were predic­tors for the failure of rapid ST segment resolution after pPCI.

Ključne reči

Array
Array
Array
Array
DOI: 10.2298/VSP160405030D

Reference

References

Eeckhout E, Kern MJ. The coronary no-reflow phenome¬non: A review of mechanisms and therapies. Eur Heart J 2001; 22(9): 729–39.

Vrints C. Pathophysiology of the no-reflow phenomenon. Acute Card Care 2009; 11(2): 69–76.

Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, et al. Task Force on the manage¬ment of ST-segment elevation acute myocardial infarction of the Europe-an Society of Cardiology (ESC). ESC Guide¬lines for the man-agement of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33(20): 2569–619.

Mazhar J, Mashicharan M, Farshid A. Predictors and out¬come of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction. Int J Cardiol Heart Vasc 2015; 10: 8–12.

Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A, et al. Predictive factors for development of the no-reflow phe-nomenon in patients with reperfused anterior wall acute myo-cardial infarction. J Am Coll Cardiol 2001; 38(2): 472–7.

Kirma C, Izgi A, Dundar C, Tanalp AC, Oduncu V, Aung SM, et al. Clinical and procedural predictors of no-reflow phenome-non after primary percutaneous coronary inter¬ventions: expe-rience at a single center. Circ J 2008; 72(5): 716–21.

Harrison RW, Aggarwal A, Ou FS, Klein LW, Rumsfeld JS, Roe MT, et al. American College of Cardiology National Cardio-vascular Data Registry. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary in¬tervention among patients with acute myocardial infarc¬tion. Am J Cardi-ol 2013; 111(2): 178–84.

Preuzimanja

Podaci o preuzimanju još nisu dostupni.